CAN FITE BIOPHAR

CANF AMEX
2.890
-0.230
-7.37%
Closed 16:00 07/23 EDT
Open
3.050
Prev Close
3.120
High
3.101
Low
2.811
Volume
81.61K
Avg Vol (3M)
254.39K
52 Week High
25.95
52 Week Low
2.660
% Turnover
2.46%
Market Cap
9.61M
1D
5D
1M
3M
1Y
5Y

Related

Webull offers CAN FITE BIOPHAR CANF stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Can Fite Biofarma Ltd is an Israel-based biopharmaceutical company. The Company develops new treatments for autoimmune diseases and cancer. The Company’s drugs are CF101 for Psoriasis treatment, RA treatment, for the treatment of Keratoconjunctictivitis Sicca, for the treatment of Glaucoma, among others; and CF102 for the treatment of liver diseases. The Company has a research infrastructure including research laboratories and animal house facilities run by the development team. Can Fite Biofarma Ltd signed distribution contracts with a Kwang Dong Pharmaceutical Co. allowing distribution of CF101 for arthritis in Korea and Seikagaku Corp. for distribution in Japan. The Company operates three subsidiaries, Ultratrend Ltd, EyeFite Ltd and OphathaliX Inc.
MORE >

Recently

Name
Price
%Change